» Articles » PMID: 24740630

Prevalence of Human Papillomavirus in Adolescent Girls Before Reported Sexual Debut

Overview
Journal J Infect Dis
Date 2014 Apr 18
PMID 24740630
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Human papillomavirus (HPV) vaccines are recommended for girls prior to sexual debut because they are most effective if administered before girls acquire HPV. Little research has been done on HPV prevalence in girls who report not having passed sexual debut in high HPV-prevalence countries.

Methods: Using attendance registers of randomly selected primary schools in the Mwanza region of Tanzania, we enrolled girls aged 15-16 years who reported not having passed sexual debut. A face-to-face interview on sexual behavior and intravaginal practices, and a nurse-assisted self-administered vaginal swab were performed. Swabs were tested for 13 high-risk and 24 low-risk HPV genotypes.

Results: HPV was detected in 40/474 (8.4%; 95% confidence interval [CI], 5.9-11.0) girls. Ten different high-risk and 21 different low-risk genotypes were detected. High-risk genotypes were detected in 5.3% (95% CI, 3.5-7.8). In multivariable analysis, only intravaginal cleansing (practiced by 20.9%) was associated with HPV detection (adjusted odds ratio = 2.19, 95% CI, 1.09-4.39).

Conclusion: This cohort of adolescent Tanzanian girls had a high HPV prevalence prior to self-reported sexual debut, and this was associated with intravaginal cleansing. This most likely reflects underreporting of sexual activity, and it is possible that intravaginal cleansing is a marker for unreported sexual debut or nonpenetrative sexual behaviors.

Citing Articles

Impact of Hormonal Contraceptives on HPV Dynamics in Adolescent Girls and Young Women: Insights from a Randomized Controlled Sub-Study in South Africa.

Tanko R, Taku O, Mbulawa Z, Phohlo K, Konstantinus I, Balle C medRxiv. 2025; .

PMID: 39867395 PMC: 11759828. DOI: 10.1101/2025.01.14.25320519.


Assessment of knowledge of human papillomavirus transmission and prevention among tertiary institution students in the Plateau Central Senatorial District, Nigeria.

Rume J, Morhason-Bello I, Oladokun A PLOS Glob Public Health. 2024; 4(9):e0003273.

PMID: 39331635 PMC: 11432872. DOI: 10.1371/journal.pgph.0003273.


Microbiological and behavioral determinants of genital HPV infections among adolescent girls and young women warrant the need for targeted policy interventions to reduce HPV risk.

Onywera H, Mabunda S, Williamson A, Mbulawa Z Front Reprod Health. 2022; 4:887736.

PMID: 36303664 PMC: 9580722. DOI: 10.3389/frph.2022.887736.


Sexual Practices During Adolescence.

Arruda E, Brito L, Prandini T, Lerri M, Reis R, Barcelos T Rev Bras Ginecol Obstet. 2020; 42(11):731-738.

PMID: 33254268 PMC: 10309252. DOI: 10.1055/s-0040-1713411.


The Vaginal Microbiota Among Adolescent Girls in Tanzania Around the Time of Sexual Debut.

Francis S, Crucitti T, Smekens T, Holm Hansen C, Andreasen A, Jespers V Front Cell Infect Microbiol. 2020; 10:305.

PMID: 32670894 PMC: 7330010. DOI: 10.3389/fcimb.2020.00305.


References
1.
Low N, Chersich M, Schmidlin K, Egger M, Francis S, van de Wijgert J . Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med. 2011; 8(2):e1000416. PMC: 3039685. DOI: 10.1371/journal.pmed.1000416. View

2.
de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N . Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007; 7(7):453-9. DOI: 10.1016/S1473-3099(07)70158-5. View

3.
Minnis A, Steiner M, Gallo M, Warner L, Hobbs M, van der Straten A . Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol. 2009; 170(7):918-24. PMC: 3888136. DOI: 10.1093/aje/kwp219. View

4.
Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, Ross D . Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis. 2012; 206(5):678-86. PMC: 3414230. DOI: 10.1093/infdis/jis407. View

5.
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F . A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009; 10(4):321-2. DOI: 10.1016/s1470-2045(09)70096-8. View